Progress in fighting cancer and infections with T cell therapy

(Technical University of Munich (TUM)) The quest to bring immunotherapy into widespread clinical use against cancer and infectious diseases has made great strides in recent years. For example, clinical trials of adoptive T cell therapy are yielding highly promising results. The latest progress is being reported at AAAS 2016 by three international leaders in the field: Professor Dirk Busch, Technical University of Munich; Professor Chiara Bonini, San Raffaele Scientific Institute; and Professor S